Insulin Therapy in Diabetes Mellitus
- 1 January 2007
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 67 (13) , 1813-1827
Abstract
The era of animal source insulins has passed and human recombinant DNA insulins are gradually being replaced because of the superior efficacy of insulin analogues. Analogue insulins are available in both rapid- and long-acting preparations. Currently available rapid-acting insulins are lispro, aspart and glulisine, and the currently available long-acting analogue basal insulins are detemir and glargine. The rapid-acting insulin analogues are also available in combination with protamine in fixed-dose pre-mixed insulins to provide a more sustained action. The chemical structure, subcutaneous behaviour, time of onset, maximal effect and duration of action of both analogue and human insulins, and how these actions can be best utilised in the diabetic patient are discussed in this review. In addition, strategies where efficacy of the available analogue insulins can be maximally utilised in both type 1 and type 2 diabetes mellitus are described. Maximal utilisation of analogue insulins will result not only in better glycaemic control, but will also minimise the frequency and severity of hypoglycaemic episodes. In addition, maximisation of glycaemic control will result in prevention, delay of onset or amelioration of both the microvascular and perhaps the macrovascular complications of diabetes.Keywords
This publication has 60 references indexed in Scilit:
- Time‐action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups*Diabetes, Obesity and Metabolism, 2006
- Treatment of type 2 diabetesPostgraduate Medicine, 2006
- Short-term Hyperglycemia in Surgical Patients and a Study of Related Cellular MechanismsAnnals of Surgery, 2006
- Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetesDiabetic Medicine, 2006
- Premixed Insulin Analogues for the Treatment of Diabetes MellitusDrugs, 2006
- Optimal timing of injection of once‐daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal‐timesDiabetic Medicine, 2005
- Reproducibility and variability in the action of injected insulinDiabetes & Metabolism, 2005
- Effect of Rosiglitazone Versus Insulin on the Pancreatic β-Cell Function of Subjects With Type 2 DiabetesDiabetes Care, 2004
- Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pensThe Lancet, 1999
- Reduced Insulin Clearance in Normal Subjects Due to Extreme HyperinsulinemiaThe American Journal of the Medical Sciences, 1988